用于脑缺血小鼠海马SOD1表达的改进灌注固定法

常规灌注固定法多用于兔和大鼠等较大动物,并存在一些不足。改进了灌注固定法流程、灌注溶液的配方、流速、用量以及灌注装置,将其用于在显微操作下制备的缺血再灌注C57BL/6N小鼠模型,并对其海马进行H.E染色和免疫组织化学SOD1基因表达。结果显示,改进的灌注固定法使组织切片结构更加清晰,海马免疫阳性神经元定位于胞浆。缺血再灌注组(24hI/R)海马神经元SOD1表达比假手术对照组(sham-o)减少,而高压氧治疗组(24hHBO)SOD1表达有所恢复。表明改进的灌注固定法用于缺血再灌注C57BL/6N小鼠海马SOD1基因表达效果良好,结果可靠。实验结果提示,高压氧的治疗机制之一可能是通过增加SOD1基因表达而实现的。     

重症肌无力小鼠模型的建立

目的建立重症肌无力小鼠模型。方法电鳗乙酰胆碱受体(TnAChR)和完全弗氏佐剂(CFA)混合物免疫C57BL/6J小鼠,经二次加强免疫后,检测肌力、腓肠肌肌电图、膈肌终板电镜、血清抗体水平等指标。结果与对照小鼠相比,发病小鼠表现出肌力减弱的症状,肌电图显示小鼠腓肠肌复合动作电位振幅幅度显著下降,电镜证实神经肌接头处突触后膜变平、皱褶减少、空泡样变性,发病小鼠血清抗体水平明显升高。结论成功建立了重症肌无力小鼠模型,有助于探讨其发病机理及探索治疗自身免疫病新的途径和方法。     

全脑缺血预处理诱导大鼠海马缺血耐受的实验研究

目的和方法：采用大鼠四血管闭塞全脑缺血模型（4－vessel occlusion,4VO）及组织病理学方法,观察预缺血的持续时间,和预缺血与其后的损伤性缺血之间的间隔时间对海马缺血耐受形成的影响。结果：缺血6min即可导致海马组织明显的神经元延迟性死亡（delayed neuron death,DND),而缺血3min不足以引起海马组织明显的DND。经过3min缺血预处理,可对间隔1d和3d后6min缺血引起的大鼠海马DND产生明显的保护作用（P＜0．01）。但是,1min缺血预处理对间隔1d后6min缺血引起的DND不产生明显影响;5min缺血预处理时间隔1d后6min缺血,以及3min缺血预处理对间隔1h后6min缺血引起的DND不但没有保护作用,反而有使海马组织损伤累积加重的趋势。结论：在4VO大鼠模型中,全脑缺血预处理确能诱导海马对缺血性损伤产生耐受,诱导海马缺血耐受所需缺血预处理的适宜期间为3min左右,预缺血与后续损伤性缺血之间需要间隔足够的时间,适宜间隔在1－3d左右。     

MST3在颞叶癫痫模型小鼠海马的表达变化

目的观察海人酸(kainic acid,KA)所致癫痫(epilepsy,EP)小鼠海马Ste20蛋白激酵素(MST3)表达水平的变化,探讨MST3在癫痫发病过程中的可能作用。方法选用成年雄性小鼠,并随机分成模型组和对照组。模型组小鼠侧脑室注射2μL(100 ng/μL)KA,分别于术后3、8、24 h收集动物标本以进行检测。使用RT-PCR和Western Blot测定MST3 mRNA含量和MST3蛋白动态表达变化,应用免疫组化观察MST3在海马的表达分布与特点。结果与正常对照组相比,模型组海马组织内MST3mRNA的表达随时间持续升高,24 h达到高峰;MST3的蛋白表达也表现出同样的动态升高趋势;术后3～24 h的模型组海马免疫组化检测显示,模型组MST3主要以海马齿状回、门回区、CA3区域表达增加为主,并且这些区域表达逐渐递增。结论随着时间的推移,MST3表达水平呈现逐渐增加趋势,可能与神经元损伤造成的凋亡之间有密切的关系,提示MST3可能在癫痫发病过程中起重要作用。     

PPARβ mRNA在全脑缺血/再灌注大鼠海马表达变化

目的探讨PPARβ mRNA在大鼠全脑缺血/再灌注损伤后的表达变化。方法采用双侧颈总动脉夹闭合并低血压的方法建立大鼠全脑缺血/再灌注模型。Morris水迷宫检测大鼠空间学习记忆能力,HE染色观察海马神经元形态变化,RT-PCR检测大鼠海马PPARβ mRNA的表达变化。结果全脑缺血/再灌注大鼠空间学习记忆能力明显下降,海马神经元核固缩;与假手术组相比,全脑缺血/再灌注后2h时PPARβ mRNA的表达明显增加,48h时达表达高峰,15d时表达下降但仍明显高于假手术组,而在30d时其表达略高于假手术组,但差异无统计学意义。结论全脑缺血/再灌注诱导大鼠海马PPARβ mRNA表达明显增加,此升高可能对全脑缺血/再灌注损伤具有保护作用。     

短暂前脑缺血小鼠海马脑红蛋白表达的动态变化

研究了小鼠短暂前脑缺血再灌注后不同时相点脑红蛋白表达的动态变化及其意义。用夹闭双侧颈总动脉的方法建立C57BL/6小鼠缺血再灌注动物模型;采用RT-PCR及Western blotting方法检测各组小鼠海马组织中脑红蛋白在转录和翻译水平表达的动态变化。结果显示,脑红蛋白在mRNA水平表达的动态变化为:与假手术对照组(100±0.00)比较,再灌注后6h(132.59±28.26,P<0.05)开始升高;24h(157.36±13.85,P<0.001)达高峰;48h(146.55±23.17,P<0.01)开始下降;72h(118.42±34.23,P>0.05)基本恢复至正常水平。脑红蛋白在蛋白水平表达的动态变化为:与假手术对照组(100±0.00)比较,再灌注后6h(111.46±23.54,P>0.05)轻微升高,24h(141.25±32.12,P<0.01)达高峰,48h(138.02±19.68,P<0.05)开始下降,72h(119.29±35.18,P>0.05)基本恢复至正常水平。结果提示,脑缺血再灌注各时相点的脑红蛋白mRNA及蛋白表达水平均增加,可能是机体的应激反应,但持续时间较短(48h以内)。     

博来霉素诱导G57BL/6与ICR小鼠肺间质纤维化模型的比较

目的探讨C57BL/6与ICR小鼠在博来霉素(BLM)致肺纤维化过程中的种属差异。方法 8周龄雌性C57BL/6小鼠19只,ICR小鼠16只,分别经尾静脉一次性注射BLM150mg/kg,观察每组小鼠体重、生存率及肺组织病理改变。结果①C57BL/6与ICR小鼠最低体重分别发生在静脉注射处置后的7d和5d,最低体重分别为注射前的65.46%和73.21%,两组间无显著的统计学差异。②C57BL/6与ICR小鼠的生存率分别为36.84%和56.25%,两组间存在显著的统计学差异。③C57BL/6小鼠BLM注射后28d,在胸膜下及血管周围形成广泛、稳定的间质纤维化病理改变,而ICR小鼠肺组织未见明显纤维化形成。C57BL/6小鼠肺纤维化病理评分明显高于ICR小鼠(P0.001)。结论 BLM诱导的肺纤维化作用在C57BL/6与ICR小鼠间存在着明显的种属差异。C57BL/6小鼠较ICR小鼠更适于复制博来霉素诱导的肺纤维化动物模型。     

C57BL／6J小鼠ES细胞系的建立及其特性分析

本文报道从C57BL/6J个鼠的囊胚中,建立了三个ES细胞系MESPU17,MESPU18,MESPU19。这些细胞的细胞学特征和强AKP反应,表明这三个细胞系具有干细胞的特征。这三个细胞系均为XY型,正常二倍体核型分别占70％、88％和59％。体外分化可形成简单类胚,体内分化可形成瘤块。与国际上通用的CCE和来自129/ter的ES细胞MESPU13相比,这三个细胞系的ES细胞较大;在体外培养时,生长较慢;细胞也较粘,进行显微注射时,很容易粘在注射针壁上。MESPU17,MESPU18进行了嵌合体制作,以BALB/c和昆明鼠的囊胚为受体,采用囊胚注射法未获嵌合体,但使用昆阴鼠的8细胞胚注射法和共培养法得到嵌合体。     

大鼠全脑缺血后海马CA1区锥体细胞DND的实验研究

据报道,脑缺血损伤能导致迟发性神经元死亡（ｄｅｌａｙｅｄｎｅｕｒｏｎａｌｄｅａｔｈ,ＤＮＤ）。有学者认为ＤＮＤ是神经兴奋毒性作用引起的细胞坏死过程,也有学者认为主要是凋亡机制参与了ＤＮＤ。我们研究发现,大鼠全脑缺血１５ｍｉｎ后再灌流４８ｈ,海马ＣＡ１区锥体细胞大量死亡,其超微结构出现细胞膜完整的胞浆浓缩和核固缩的凋亡样形态学改变,并且蛋白合成抑制剂放线菌酮对ＣＡ１区锥体细胞的脑缺血损伤具有明显的保护作用。说明脑缺血后锥体细胞的死亡需要一定的时间合成新的蛋白质,从而激活细胞内部死亡程序。提示凋亡机制参与全脑缺血后ＤＮＤ。     

肢体缺血预处理减少大鼠全脑缺血再灌注诱导的海马CA1区锥体神经元凋亡

探探讨肢体缺血预处理(limb ischemic preconditioning,LIP)对大鼠全脑缺血再灌注后海马CA1区锥体细胞凋亡的影响。46只大鼠椎动脉凝闭后分为假手术组、肢体缺血组、脑缺血组、LIP组。重复夹闭大鼠双侧股动脉3次(每次10min,间隔10min)作为LIP,之后立即夹闭双侧颈总动脉进行全脑缺血8min后再灌注。DNA凝胶电泳、TUNEL和吖啶橙/溴乙锭(AO/EB)双染技术从生化和形态学方面观察海马神经元凋亡的情况。凝胶电泳显示,脑缺血组出现了凋亡特征性DNA梯状条带,而LIP组无上述条带出现。与脑缺血组比较,LIP可明显减少海马CAI区TUNEL阳性神经元数(17.8±5.8vs 69.8±12,P<0.01)。AO/EB染色也显示LIP可明显减少脑缺血再灌注引起的神经元凋亡。以上结果提示,LIP可抑制脑缺血再灌注后海马神经元的凋亡,进而减轻脑缺血再灌注损伤,提供脑保护作用。     

Prenatal expression of N-acetyltransferases in C57Bl/6 mice

Exposure to carcinogens such as 4-aminobiphenyl (4ABP), found in tobacco smoke and other combustion products, results in the formation of detectable levels of 4ABP-hemoglobin adducts in cord blood and 4ABP-DNA adducts in conceptal tissue. The presence of these adducts requires that the parent compound undergo biotransformation. When exposure occurs in utero, the maternal, placental and conceptal tissues are all possible sites for the formation of DNA-reactive products. One step in the activation of 4ABP is catalyzed by N-acetyltransferases (NAT). The expression of NAT was evaluated in gestational day (GD) 10-18 conceptal tissues from C57Bl/6 mice. There was a quantitative increase in NAT1 and NAT2 mRNAs with increasing gestational age that was also reflected in age-related changes in functional protein measured as 4ABP-NAT activity. The ability to acetylate 4ABP increased from GD10 to 18 and was lower in conceptal tissue than in adult liver. The potential toxicologic significance of prenatal NAT expression was assessed by formation of 4ABP-DNA adducts. At GD 15 and 18, 4ABP-DNA adducts were detected by immunohistochemistry 24 h following a single oral dose of 120 mg 4ABP/kg. Based on nuclear fluorescence, conceptual 4ABP-DNA adducts were present at similar levels at GD15 and 18. Levels of 4ABP-DNA adducts were significantly higher in maternal liver compared with the conceptus. Results from this study show that both NAT genes were expressed prenatally and that functional enzymes were present. These data support the possible in situ generation of reactive products by the conceptus. The relative contributions of maternal activation of 4ABP and that by the conceptus remain to be determined.     

Dietary resveratrol supplementation normalizes gene expression in the hippocampus of streptozotocin-induced diabetic C57Bl/6 mice

Diabetes is associated with cognitive impairment and brain aging, with alterations in hippocampal neurogenesis and synaptic plasticity implicated in these changes. As the prevalence of diabetes continues to rise, readily implemented strategies are increasingly needed in order to protect the brain’s cognitive functions. One possibility is resveratrol (RES) (3,5,4- trihydroxystilbene), a polyphenol of the phytoalexin family that has been shown to be protective in a number of neuropathology paradigms. In the present study, we sought to determine whether dietary supplementation with RES has potential for the protection of cognitive functions in diabetes. Diabetes was induced using streptozotocin, and once stable, animals received AIN93G rodent diet supplemented with RES for 6 weeks. Genome-wide expression analysis was conducted on the hippocampus and genes of interest were confirmed by quantitative, real-time polymerase chain reaction. Genome-wide gene expression analysis of the hippocampus revealed that RES supplementation of the diabetic group resulted in 481differentially expressed genes compared to non-supplemented diabetic mice. Intriguingly, gene expression that was previously found significantly altered in the hippocampus of diabetic mice, and that is implicated in neurogenesis and synaptic plasticity (Hdac4, Hat1, Wnt7a, ApoE), was normalized following RES supplementation. In addition, pathway analysis revealed Jak-Stat signaling was the most significantly enriched pathway. The Jak-Stat pathway induces a pro-inflammatory signaling cascade, and we found most genes involved in this cascade (e.g. Il15, Il22, Socs2, Socs5) had significantly lower expression following RES supplementation. These data indicate RES could be neuroprotective and beneficial for the maintenance of cognitive function in diabetes.     

Orexin-1 receptor expression after global ischemia in mice

Orexins are neuropeptides that have a range of physiological effects including the regulation of feeding behavior and the sleep-wakefulness cycle. Recently, we reported that level of orexin A in spinal fluid was decreased in the patients of some neurodegenerative diseases and it is considered that orexin A and the receptors might be related to central nervous system disorders. However, the expression and localization of orexin receptors is not elicited well. Therefore, the purpose of this study is to investigate the time-dependent changes and the cellular localization of orexin receptor focusing on orexin-1 receptor (OX1R) in the mouse brain after transient common carotid artery occlusion (tCCAO) model by using immunohistochemical techniques. OX1R immunoreactivity dramatically increased and peaked in the hippocampus and cortex 2 days after tCCAO, but remained unchanged in the hypothalamus. Using double-immunohistochemistry, the OX1R immunopositive cells at 2 days after tCCAO were co-localized not only with neuronal marker, NeuN-immunoreactivity but also with astroglial and oligodendroglial markers, GFAP- and CNPase-immunoreactivities, respectively. These results suggested that OX1R is induced other cells in addition to the neurons during stress such as ischemia and orexins and its receptor might play an important role for ischemic insult.     

C57/BL6癫痫小鼠海马齿状回DCX和GFAP表达的时程变化

目的：观察C57/BL6癫痫小鼠海马神经元DCX和GFAP表达的时程变化,为神经元发生,发育和星形胶质细胞的变化提供理论基础。方法：应用海人藻酸建立小鼠癫痫模型,应用免疫荧光组织化学方法检测海马齿状回不同时间点双皮质醇,胶质纤维酸性蛋白的表达。结果：与对照组相比,癫痫发生后3天7、天,海马齿状回DCX阳性神经元的免疫荧光强度明显增强;GFAP阳性神经元的免疫荧光强度在癫痫发生后持续的一周内较对照组均见明显持续表达增强。结论：小鼠癫痫后会引起海马星形胶质细胞的活化,同时发病早期神经元已经出现再生标记物的增加。     

Differential expression of neurotrophins in postnatal C57BL/6 mice striatum

Neurotrophin expression in early stages of development is crucial for brain assembly and function. In particular, postnatal expression of neurotrophins has not been well documented in the neostriatum and in general neurotrophins or their receptor mRNA's are normally reported, but not protein expression. In the present study, immunocytochemical expression of BDNF, NT-3 and NT-4/5 was characterized in striatal tissue of C57BL/6 mice at postnatal days 10^th (P10), 21^st (P21), 42^nd (P42) and 80^th (P80).     

Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment

Endoglin (CD105) is a homodimeric transmembrane glycoprotein strongly related to transforming growth factor (TGF)-beta signaling and many pathological states. In this study, we wanted to evaluate whether endoglin is expressed in normocholesterolemic and hypercholesterolemic C57BL/6J mice as well as whether it is affected by atorvastatin treatment in these mice. C57BL/6J mice were fed with chow diet or an atherogenic diet for 12 weeks after weaning. In 2 atorvastatin-treated groups, mice were fed the same diets (chow or atherogenic) as described above except atorvastatin was added at the dosage of 10 mg x kg(-1) x day(-1) for the last 8 weeks before euthanasia. Biochemical analysis of blood samples revealed that administration of atherogenic diet significantly increased levels of total cholesterol, VLDL, LDL, and decreased levels of HDL. Atorvastatin treatment resulted in a significant decrease in total cholesterol and VLDL only in mice fed by atherogenic diet. Quantitative stereological analysis revealed that atorvastatin significantly decreased endothelial expression of endoglin in C57BL/6J mice fed the atherogenic diet. In conclusion, we demonstrated that endothelial expression of endoglin is upregulated by hypercholesterolemia and decreased by the hypolipidemic effect of atorvastatin in C57BL/6J mice, suggesting that endoglin expression could be involved in atherogenesis.     

异丙酚对全脑缺血/再灌注大鼠海马iNOS表达的影响

目的观察异丙酚对全脑缺血/再灌注大鼠海马神经元诱导型一氧化氮合酶(iNOS)表达的影响,探讨异丙酚对迟发性脑神经元损伤保护作用机制。方法采用Pulsinelli-Brierley四血管阻断法制备全脑缺血模型。全脑缺血20min再灌注24h后断头取脑,采用Western blot方法检测大鼠海马iNOS的蛋白表达。结果与缺血/再灌注组相比较,异丙酚处理组大鼠海马iNOS蛋白表达明显降低,存活的神经元数目明显增加,统计结果差异均有显著性(P<0.05或0.01)。结论异丙酚通过抑制iNOS蛋白表达对大鼠脑迟发性神经元损伤起保护作用。     

Ethanol consumption affects lipoprotein lipase gene expression in C57BL/6 mice

The activity of lipoprotein lipase (LPL) is increased after alcohol consumption and can contribute to an increased level of HDL-cholesterol, which is considered to play a key role in the ethanol-mediated protective effect against cardiovascular disease. The increase in HDL-cholesterol concentration can be also due to an ethanol-enhanced synthesis and secretion of apolipoprotein A-I (apo A-I) from hepatocytes. Therefore, the hypothesis that ethanol consumption affects the LPL and apo A-I gene (LPL and APOA1, respectively) expression was tested in male C57BL/6 mice drinking 5 % ethanol or water and fed a standard chow or high-fat (HF) diet for 4 weeks. The LPL expression was determined in the heart, epididymal and dorsolumbal adipose tissues, the APOA1 expression in the liver. Alcohol consumption did not affect lipid and lipoprotein concentrations in the serum. The LPL expression was increased in the heart of mice given ethanol and HF diet compared to mice on chow and ethanol (p<0.001) and was also increased in epididymal fat in mice given ethanol and HF diet compared to mice on water and HF diet (p<0.05). Neither LPL expression in dorsolumbal fat nor APOA1 expression in the liver were affected by ethanol consumption. Our data suggest that ethanol consumption upregulates LPL expression in a tissue- and diet-dependent manner.